Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-17

FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tolterodine tartrate submitted by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolterodine tartrate (Detrol) (Tolterodine tartrate)

Snippet

SUPPL AP for TOLTERODINE TARTRATE (TOLTERODINE TARTRATE)